Central Pharmaceutical Joint Stock Company No3
Logotype for Central Pharmaceutical Joint Stock Company No3

Central Pharmaceutical Joint Stock Company No3 (DP3) investor relations material

Central Pharmaceutical Joint Stock Company No3 has been private

Central Pharmaceutical Joint Stock Company No3 Q4 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Central Pharmaceutical Joint Stock Company No3
Q4 2025 earnings summary20 Jan, 2026

Executive summary

  • Net revenue for 2025 reached VND 438.0 billion, up from VND 417.5 billion year-over-year, with Q4 net revenue at VND 131.6 billion, a 13% increase from Q4 2024.

  • Net profit after tax for 2025 was VND 153.6 billion, up 26.8% from VND 121.2 billion in 2024.

  • Total assets at year-end 2025 were VND 607.8 billion, down from VND 756.2 billion at the start of the year.

Financial highlights

  • Gross profit for 2025 was VND 287.7 billion, up from VND 276.1 billion in 2024.

  • Operating profit for 2025 reached VND 192.6 billion, a 26.8% increase year-over-year.

  • EPS for 2025 was VND 7,142, compared to VND 5,636 in 2024.

  • Cash and cash equivalents at year-end were VND 4.5 billion, down from VND 13.7 billion at the start of the year.

Outlook and guidance

  • The company continues to focus on pharmaceutical production, trading, and expansion of commercial services.

Strategy behind cash to short-term investment shift
Purpose of new short-term bank loans?
Explain negative selling expenses in Q4 2025
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Central Pharmaceutical Joint Stock Company No3 earnings date

Logotype for Central Pharmaceutical Joint Stock Company No3
Q1 202618 May, 2026
Central Pharmaceutical Joint Stock Company No3
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Central Pharmaceutical Joint Stock Company No3 earnings date

Logotype for Central Pharmaceutical Joint Stock Company No3
Q1 202618 May, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Central Pharmaceutical Joint Stock Company No3 is a Vietnam-based company engaged in the manufacturing and distribution of pharmaceutical products. The company produces a range of medicines including tablets, capsules, powders, and syrups across various therapeutic categories. It also distributes medical equipment, health supplements, and raw pharmaceutical ingredients. Central Pharmaceutical Joint Stock Company No3 serves hospitals, pharmacies, and healthcare institutions within Vietnam. The company is headquartered in Hanoi, Vietnam, and its shares are listed on the HNX.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage